Detalhe da pesquisa
1.
Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity.
Eur J Pediatr
; 182(10): 4633-4645, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555973
2.
Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
J Pediatr Gastroenterol Nutr
; 75(6): 717-723, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084231
3.
Correction to: Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP.
Eur J Pediatr
; 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38878062
4.
Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study.
Eur J Pediatr
; 180(9): 3039-3040, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34027626
5.
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.
Paediatr Drugs
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38780740
6.
Antibiotics in respiratory tract infections in hospital pediatric emergency departments.
Arch Bronconeumol
; 50(9): 375-8, 2014 Sep.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-24629757